Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,890 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
Gales AC, Jones RN, Sader HS. Gales AC, et al. Among authors: jones rn. Clin Microbiol Infect. 2006 Apr;12(4):315-21. doi: 10.1111/j.1469-0691.2005.01351.x. Clin Microbiol Infect. 2006. PMID: 16524407
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
Sader HS, Rhomberg PR, Huband MD, Critchley IA, Stone GG, Flamm RK, Jones RN. Sader HS, et al. Among authors: jones rn. J Clin Microbiol. 2018 May 25;56(6):e01960-17. doi: 10.1128/JCM.01960-17. Print 2018 Jun. J Clin Microbiol. 2018. PMID: 29563198 Free PMC article.
Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
Pfaller MA, Flamm RK, Jones RN, Farrell DJ, Mendes RE. Pfaller MA, et al. Among authors: jones rn. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5393-9. doi: 10.1128/AAC.00881-16. Print 2016 Sep. Antimicrob Agents Chemother. 2016. PMID: 27353270 Free PMC article.
Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin.
Mendes RE, Farrell DJ, Flamm RK, Sader HS, Jones RN. Mendes RE, et al. Among authors: jones rn. J Clin Microbiol. 2015 Aug;53(8):2727-30. doi: 10.1128/JCM.00611-15. Epub 2015 May 27. J Clin Microbiol. 2015. PMID: 26019194 Free PMC article.
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Sader HS, et al. Among authors: jones rn. Int J Antimicrob Agents. 2015 Jul;46(1):53-9. doi: 10.1016/j.ijantimicag.2015.02.022. Epub 2015 Apr 14. Int J Antimicrob Agents. 2015. PMID: 25956844
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
Mendes RE, Farrell DJ, Sader HS, Flamm RK, Jones RN. Mendes RE, et al. Among authors: jones rn. J Antimicrob Chemother. 2015 Feb;70(2):498-504. doi: 10.1093/jac/dku421. Epub 2014 Oct 31. J Antimicrob Chemother. 2015. PMID: 25362568 Clinical Trial.
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).
Farrell DJ, Sader HS, Flamm RK, Jones RN. Farrell DJ, et al. Among authors: jones rn. Int J Antimicrob Agents. 2014 Jun;43(6):533-9. doi: 10.1016/j.ijantimicag.2014.01.032. Epub 2014 Mar 26. Int J Antimicrob Agents. 2014. PMID: 24856078
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
Sader HS, Farrell DJ, Flamm RK, Jones RN. Sader HS, et al. Among authors: jones rn. J Infect. 2014 Sep;69(3):266-77. doi: 10.1016/j.jinf.2014.04.004. Epub 2014 Apr 26. J Infect. 2014. PMID: 24780763
Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012).
Sader HS, Farrell DJ, Flamm RK, Jones RN. Sader HS, et al. Among authors: jones rn. Int J Antimicrob Agents. 2014 May;43(5):465-9. doi: 10.1016/j.ijantimicag.2014.01.018. Epub 2014 Feb 17. Int J Antimicrob Agents. 2014. PMID: 24636430
1,890 results
Jump to page
Feedback